1-(4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)-3-(furan-3-yl)prop-2-en-1-one

Catalog No. :
ACKOSF786
CAS No. :
70842-93-2
Molecular Formula :
C21H23N5O4
Molecular Weight :
409.45

IUPAC Name:(E)-1-(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)-3-(furan-3-yl)prop-2-en-1-one

1-(4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)-3-(furan-3-yl)prop-2-en-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)-3-(furan-3-yl)prop-2-en-1-one
IUPAC Name(E)-1-(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)-3-(furan-3-yl)prop-2-en-1-one
Molecular FormulaC21H23N5O4
Molecular Weight409.45
SMILESO=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)/C=C/C4=COC=C4
InChI KeyNNMCIWBYFKCLHG-ONEGZZNKSA-N
Synonym2-Propen-1-one, 1-[4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-3-(3-furanyl)-
CAS No.70842-93-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACKOSF786 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRQHE063 route compound structure diagram
    ACRQHE06360548-08-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKOSF786 route product structure diagram
    ACKOSF78670842-93-2
Inquiry

2. ACKOSF786 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAMIF807 route compound structure diagram
    ACAMIF80722037-28-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKOSF786 route product structure diagram
    ACKOSF78670842-93-2
Inquiry

Comments (0)